HealthLynked signs Definitive Agreement to Acquire HCFM,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
17
HealthLynked signs Definitive Agreement to Acquire HCFM, Adding Significant Revenue to its Health Services Division

NAPLES, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp (OTCQB: HLYK),  a leading digital healthcare business, announced today that it has entered into a definitive agreement to acquire Hughes Center for Functional Medicine, P.A. ( HCFM) for $750,000 in cash, $750,000 in shares of HealthLynked common stock and $500,000 in a three-year performance-based payout.

HCFM is a leader in functional medicine, focusing on Neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Multiple Sclerosis along with other cutting-edge treatments to improve health and slow aging, including hormones, thyroid, weight loss, wellness and prevention. Income sources include seeing patients, an IV room, Hyperbaric Oxygen Chambers, Ozone, UVlrx and Supplements.

“The acquisition of HCFM expands our health services division and significantly adds to our profitability.  HCFM provides expertise in Neurodegenerative conditions and functional medicine with cutting edge therapies.” said Michael Dent, M.D., HealthLynked’s Chairman and CEO.  “As we continue to expand our network and provide algorithms around new and innovative treatments, we are confident that this will bring significant value to our patient members. ” Benefits of the Transaction

  • Revenue and Profit Increase.  HealthLynked expects the acquisition to contribute $3.0 million of revenue and $500 thousand in EBITDA in year one, more than doubling the Company’s revenues and reducing cash burn by over 50%.                                                                                                        
  • Expansion of Healthcare Services.  HCFM has well-established relationships and cutting-edge protocols for treating neurogenerative disorders and optimizing the health of older patients. These customized therapies have been shown to improve patient outcomes for a wide range of disorders. Functional Medicine is one of the fastest growing and most highly profitable areas of healthcare making it an ideal acquisition for HealthLynked.                                                                                                                             
  • Expansion of Healthcare Data Specific to Functional Medicine and Antiaging.  HealthLynked will draw on the best attributes from each company to improve the quality of service for all of our patient members. HCFM patients will benefit from HealthLynked’s digital technology to connect and analyze patient members healthcare data to monitor treatments and improve outcomes.  HealthLynked members will benefit from HCFM health services and extensive experience in functional medicine.                                                                                                                            
  • Four-year Consultancy Agreement with Dr. Pamela Hughes on the HLYK Advisory Board. The acquisition also includes a four-year consultancy agreement with Dr. Pamela Hughes on the HealthLynked Advisory Board where she will provide her expertise in functional medicine to help the Company’s development team to write algorithms utilizing the HealthLynked software to make recommendations to patient members on a wide range of medical conditions.                                                                                                                              
  • Advisors K&L Gates LLP is serving as legal counsel for the acquisition. George O’Leary, Chief Financial Officer of HealthLynked, stated, “We expect that this will be the first of many acquisitions for HealthLynked focused on:
    • Profitable health service businesses;
    • Digital healthcare including online marketing and telemedicine companies; and
    • Data driven healthcare businesses, such as Accountable Care Organizations (ACOs)

Our acquisition model of purchasing high growth, profitable health service businesses paying 4 times adjusted EBITDA, with 35% in cash, 35% in HLYK stock, and 30% in three year performance based payouts will complement our digital healthcare and ACO acquisition strategies.”                        

About HealthLynked Corp.

HealthLynked Corp. provides a solution for both patient members and providers to improve healthcare through the efficient exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare. Members enter their medical information, including medications, allergies, past surgeries and personal health records, in one convenient online and secure location, free of charge.

Participating healthcare providers can connect with their current and future patients through the system. Other benefits to providers include the ability to utilize the HealthLynked marketing tools to connect with their active and inactive patients to improve patient retention, access more accurate and current patient information, provide more efficient online scheduling and to fill last minute cancellations using our “real time appointment scheduling” all within our mobile application. Healthcare providers pay a monthly fee to access these HealthLynked services.

For additional information about HealthLynked Corp. visit www.healthlynked.com and connect with HealthLynked on Twitter , Facebook , and LinkedIn .

Forward Looking Statements

Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Our actual results, including as a result of any acquisitions, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “will,” “would” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the “ Risk Factors ” section of our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q and in other reports we have filed with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov .                                        

Company Contact: George O’Leary Chief Financial Officer goleary@healthlynked.com

Investor Relations contact: Jim Hock Hanover International Inc. Investor Relations jh@hanoverintlinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 27

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 311

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 50

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 257

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 456

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 35

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading

Top 5 Most Recently Viewed Articles

HeyGears Unveils Advanced 3D Printing Innovation for Creatives

Updated Category News Views 284

HeyGears Set to Launch the New UltraCraft Reflex Series 3D Printer HeyGears, a well-known name in the 3D printing world, is about to introduce its newest creation, the UltraCraft Reflex series 3D printer. This innovative product is designed to deliver outstanding speed and precision, catering to the varied needs of engineers, designers, and 3D printing fans. Join Us for...

Continue Reading
Willamette Valley Vineyards: A Toast to Triple Triumph

Updated Category News Views 22

A Legendary Achievement in Wine Tasting What does it take to stand out in a sea of thousands in the wine industry? Well, Willamette Valley Vineyards seems to have cracked the code, clenching the USA TODAY’s #1 Best Wine Tasting Room accolade for a record three years in a row. Now, that’s one juicy tidbit to savor for a moment. A Devotion to Excellence Found in the...

Continue Reading
UTR Sports Revolutionizes College Tennis Team Rankings System

Updated Category News Views 383

UTR Sports Unveils Innovative College Team Rankings UTR Sports continues its mission to elevate the world of college tennis with the launch of its groundbreaking College Team Rankings. This new ranking system highlights the top college teams across various divisions, including Division I, Division II, Division III, and NAIA, setting a new standard in collegiate athletics....

Continue Reading
Profiting from KKR Stock: 15-Year Investment Insights

Updated Category News Views 130

Understanding KKR's Impressive Stock Performance Over the past 15 years, KKR (NYSE: KKR) has consistently outperformed the broader market, achieving an annualized return of 16.02%, exceeding market averages by 4.06%. This level of performance is a testament to KKR's strong business model and investment strategies, which have been pivotal in growing investor wealth. The...

Continue Reading
Banco Santander Chile Reports Strong Earnings Growth in 2024

Updated Category News Views 310

Banco Santander Chile's Strong Performance in 2024 Banco Santander Chile recently shared its financial results for the third quarter of 2024, demonstrating a remarkable improvement in profitability and operational metrics. As of September 30, 2024, the bank reported a significant rise in net income, showcasing solid operational efficiency and customer satisfaction amidst...

Continue Reading